Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales. (2024)
Attributed to:
Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2023.100816
PubMed Identifier: 38162515
Publication URI: http://europepmc.org/abstract/MED/38162515
Type: Journal Article/Review
Volume: 37
Parent Publication: The Lancet regional health. Europe
ISSN: 2666-7762